pSivida Corp Reports Third Quarter Fiscal Year 2013 Results

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

pSivida Corp. (NASDAQ: PSDV)(ASX: PVA), a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced financial results for its third quarter ended March 31, 2013.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC